Behavior Change InterventionsNCT07814521
Clinician Motivational Interviewing Training Evaluation
A study testing MI training in people with Behavior Change Interventions and Evaluation, run by Geisinger Clinic at 1 site in United States.
Trial summary
The goal of this study is to evaluate the impact of motivational interviewing (MI) training for Geisinger clinicians on their patients' health outcomes. Clinicians will be randomly assigned to attend or not attend mandated MI training, which will be provided at one of several sessions offered beginning in August 2026. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Behavior Change Interventions, Evaluation, Training Effectiveness
- What is being tested?
- MI training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180,000 participants
- Where
- 1 siteUnited States
- Study dates
- 18 Aug 2026to Aug 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
None listed.
Who cannot join
- N/A
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site
Geisinger Health System
Danville, Pennsylvania, 17822
About this study
Official title: Evaluating Clinician Motivational Interviewing Training to Improve Patient Outcomes
The goal of this study is to evaluate the impact of motivational interviewing (MI) training for Geisinger clinicians on their patients' health outcomes. Clinicians will be randomly assigned to attend or not attend mandated MI training, which will be provided at one of several sessions offered beginning in August 2026. Randomization will be stratified by department to ensure participant balance and that participating departments maintain necessary staffing levels during the training period. The study will assess whether there is a significant increase in patients' positive health behaviors and outcomes, as reflected in an index measure of multiple outcomes that may reasonably be facilitated by MI training: vaccinations and health screenings as reflected in electronic health record care gaps. Smoking cessation and other lifestyle modifications, preventive medication adherence, and behavioral health use may also be examined as part of an overall measure of MI impact. For each clinician assigned to the study, all patients they see in the 90-day period following the (would-be) date of that clinician's training will be identified and enrolled in the study. Outcome timeframes will then be relative to each unique patient's first encounter following (would-be) training.
- Conditions
- Behavior Change Interventions, Evaluation, Training Effectiveness, Health Services Research, Healthcare Provider Training, Patient-provider Communication
- Being tested
- MI training
- Keywords
- Behavior change interventions, Evaluation, Training effectiveness, Health services research, Healthcare provider training, Patient-provider communication, Motivational interviewing
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MI trainingBehavioural
Clinicians will be instructed to register for one MI training session that will be conducted live and in person, with possible virtual training available for those unable to attend in person
| Study group | Role | What they receive |
|---|---|---|
| MI training | Experimental | Clinician is assigned to attend an MI training session Receives: Behavioral: MI training |
| Control | No intervention | Clinician is not assigned to MI training |
What is being measured
The primary outcome is the main question the study is designed to answer.
Proportion of care gaps addressed
Proportion of open care gaps closed
Measured: Within 180 days following initial patient encounter, as of day following (would-be) assigned MI training session
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Sep 2026
- Study start18 Aug 2026
- Primary completionAug 2028 (estimated)
- Study completionAug 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Behavior Change InterventionsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- The design is intent-to-treat, such that clinicians randomized to training will be included in the treatment group, regardless of whether they attended the (in-person) training session.
- Masking
- None (open label)
- Enrolment
- 180,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Geisinger Clinic
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Amir Goren, Geisinger Clinic
- Investigators
- Amir Goren, PhD, Principal investigator, Geisinger Clinic
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07814521
- Sponsor's protocol ID
- 2026-0493
- Status last verified
- Aug 2026
- First submitted
- 17 Aug 2026
- Last updated
- 11 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 11 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Evaluating Clinician Motivational Interviewing Training to Improve Patient Outcomes
- ClinicalTrials.gov ID
- NCT07814521
- Acronym / sponsor ID
- 2026-0493
- Conditions
- Behavior Change Interventions, Evaluation, Training Effectiveness, Health Services Research, Healthcare Provider Training, Patient-provider Communication
- Keywords
- Behavior change interventions, Evaluation, Training effectiveness, Health services research, Healthcare provider training, Patient-provider communication, Motivational interviewing
- Study type
- Interventional
- Recruitment status
- Enrolling by invitation
- Enrolment
- 180,000 participants (estimated)
- Lead sponsor
- Geisinger ClinicUniversity, hospital or other
- Study start
- 18 Aug 2026 (actual)
- Primary completion
- Aug 2028 (estimated)
- Study completion
- Aug 2028 (estimated)
- First posted
- 11 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The goal of this study is to evaluate the impact of motivational interviewing (MI) training for Geisinger clinicians on their patients' health outcomes. Clinicians will be randomly assigned to attend or not attend mandated MI training, which will be provided at one of several sessions offered beginning in August 2026. Randomization will be stratified by department to ensure participant balance and that participating departments maintain necessary staffing levels during the training period. The study will assess whether there is a significant increase in patients' positive health behaviors and outcomes, as reflected in an index measure of multiple outcomes that may reasonably be facilitated by MI training: vaccinations and health screenings as reflected in electronic health record care gaps. Smoking cessation and other lifestyle modifications, preventive medication adherence, and behavioral health use may also be examined as part of an overall measure of MI impact. For each clinician assigned to the study, all patients they see in the 90-day period following the (would-be) date of that clinician's training will be identified and enrolled in the study. Outcome timeframes will then be relative to each unique patient's first encounter following (would-be) training.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- The design is intent-to-treat, such that clinicians randomized to training will be included in the treatment group, regardless of whether they attended the (in-person) training session.
| Arm | Type | Receives |
|---|---|---|
| MI training | Experimental | Behavioral: MI trainingClinician is assigned to attend an MI training session |
| Control | No intervention | –Clinician is not assigned to MI training |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (0 listed)
Key exclusion criteria (1 listed)
- N/A
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MI trainingClinicians will be instructed to register for one MI training session that will be conducted live and in person, with possible virtual training available for those unable to attend in person | Behavioural | MI training |
Primary outcome
Proportion of care gaps addressed
Time frame: Within 180 days following initial patient encounter, as of day following (would-be) assigned MI training session
Proportion of open care gaps closed
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 11 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for Behavior Change Interventions
Recruiting
Unconscious Mind Training
Memory Encoding, Memory
Not yet recruiting
Optical Diagnosis of Neoplasia Using Artificial Intelligence
Polyps Colorectal, Colonoscopy
Not yet recruiting
Digital Resistance Training for Midlife Women Using GLP-1
Women's Health, Obesity & Overweight
Not yet recruiting
Reset: Enhancing Weight Loss in a Digital Intervention
Obesity, Overweight
Recruiting
Informing Low-acuity Emergency Department Patients of Non-emergent Resources (2)
Emergency Service, Hospital, Behavior Change Interventions
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Amir Goren, PhD principal investigator
Geisinger Clinic
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing MI training in people with Behavior Change Interventions and Evaluation, run by Geisinger Clinic at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 0 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: enrolling by invitation, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Proportion of care gaps addressed (time frame: Within 180 days following initial patient encounter, as of day following (would-be) assigned MI training session). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026; AzTrials last refreshed its copy on 26 Oct 2026.